ACTA2 and interstitial lung disease: module 5 and 6), over-expression of ZEB1 (Figure 4A, module 6), and increased levels of mesenchyme-associated genes such as ACTA2, CDH2 and VIM in ILD patients (Figure 4A, module 1).